Share on LinkedInShare on LinkedIn

ARTICLE · 18 APRIL 2024

Petition Denied For Lacking Section 112(f) Construction And Fintiv

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

On March 7, 2024, the PTAB denied institution in 10x Genomics, Inc. v. President and Fellows of Harvard College, IPR2023-01299, Paper 15 (PTAB Mar. 7, 2024) ("Decision").

United StatesIntellectual Property

On March 7, 2024, the PTAB denied institution in 10x Genomics, Inc. v. President and Fellows of Harvard College, IPR2023-01299, Paper 15 (PTAB Mar. 7, 2024) ("Decision"). The PTAB denied institution on two separate grounds: (1) the Petitioner, 10x Genomics, did not properly assert a Section112(f) construction in the alternative in its Petition under 37 C.F.R. §42.104(b)(3); and (2) the circumstances of a parallel U.S. District Court of Delaware proceeding called for a discretionary denial under 35 U.S.C. §314(a) under Apple Inc. v. Fintiv, Inc., IPR2020-00019, Paper 11 (PTAB Mar. 20, 2020) (precedential) ("Fintiv").

The docket for the parallel proceeding can be found at 10X Genomics, Inc. et al v. Vizgen, Inc., Docket No. 1:22-cv-00595 (D. Del. May 3, 2022). The counterclaim for infringement relevant to the patent in the Petition was filed August 30, 2022. Decision at 2.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from